BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23314935)

  • 1. Untethering of herniated left optic nerve after dopamine agonist treatment for giant prolactinoma.
    Gkekas N; Primikiris P; Georgakoulias N
    Acta Neurochir (Wien); 2013 Mar; 155(3):495-6. PubMed ID: 23314935
    [No Abstract]   [Full Text] [Related]  

  • 2. Her vision was tied down.
    Dorotheo EU; Tang RA; Bahrani HM; Schiffman JS; Bhatti MT; Lewis SB
    Surv Ophthalmol; 2005; 50(6):588-97. PubMed ID: 16263371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene?
    Papanastasiou L; Fountoulakis S; Pappa T; Liberopoulos K; Malliopoulos D; Markou A; Piaditis G
    Hormones (Athens); 2014; 13(2):290-5. PubMed ID: 24776630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chiasmal herniation as a complication of bromocriptine therapy.
    Taxel P; Waitzman DM; Harrington JF; Fagan RH; Rothfield NF; Chen HH; Malchoff CD
    J Neuroophthalmol; 1996 Dec; 16(4):252-7. PubMed ID: 8956160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transnasal Transsphenoidal Elevation of Optic Chiasm in Secondary Empty Sella Syndrome Following Prolactinoma Treatment.
    Cobb MIH; Crowson M; Mintz-Cole R; Husain AM; Berger M; Jang D; Codd P
    World Neurosurg; 2018 Apr; 112():250-253. PubMed ID: 29421446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.
    Dhanwal DK; Sharma AK
    Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tethered brain. Case illustration.
    Yemisci M; Dogulu CF; Kansu T; Saatci I; Ozgen T
    J Neurosurg; 2000 Jul; 93(1):146. PubMed ID: 10883921
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumoral pituitary apoplexy and cocaine consumption].
    Ramos-Zúñiga R; Hasslacher-Arellano F; González-Jara G; Gómez-Ríos D; Vázquez-Moreno J; Camarena-Pérez H
    Rev Neurol; 2009 Jan 16-31; 48(2):107-8. PubMed ID: 19173209
    [No Abstract]   [Full Text] [Related]  

  • 9. Longitudinal splitting of optic pathways by non-functioning pituitary macroadenoma: report of two cases.
    Gagliardi F; Boari N; Losa M; Mortini P
    Acta Neurochir (Wien); 2010 Jun; 152(6):1065-8; discussion 1068. PubMed ID: 19826754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional assessment before and after interventions on the optic chiasm system].
    Menke E; Osarovsky E; Reitner A; Matula C
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):33-7. PubMed ID: 12407933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous defect of visual fields and loss of libido--a coincidence?].
    Jenni S; Seiler R; Christ ER; Stettler C
    Praxis (Bern 1994); 2006 Dec; 95(49):1925-30. PubMed ID: 17212311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed visual loss from optochiasmatic arachnoiditis after resection of craniopharyngioma.
    Carreras EM; Lyons CJ; Cochrane DD
    J Neurosurg Pediatr; 2014 May; 13(5):520-4. PubMed ID: 24606404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endonasal endoscopic transsphenoidal chiasmapexy using a clival cranial base cranioplasty for visual loss from massive empty sella following macroprolactinoma treatment with bromocriptine: case report.
    Alvarez Berastegui GR; Raza SM; Anand VK; Schwartz TH
    J Neurosurg; 2016 Apr; 124(4):1025-31. PubMed ID: 26339851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transsphenoidal treatment of secondary empty sella syndrome using low field strength intraoperative MRI: case report.
    Kubben PL; Cornips EM; Looij BJ; Beuls EA
    Minim Invasive Neurosurg; 2010 Aug; 53(4):198-202. PubMed ID: 21132613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI visualization of complete bilateral optic nerve involvement by pituitary adenoma: a case report.
    Arita K; Uozumi T; Yano T; Sumida M; Muttaqin Z; Hibino H; Yonezawa M
    Neuroradiology; 1993; 35(7):549-50. PubMed ID: 8232889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant craniopharyngioma with blindness reversed by surgery.
    al-Wahhabi B; Choudhury AR; al-Moutaery KR; Aabed M; Faqeeh A
    Childs Nerv Syst; 1993 Aug; 9(5):292-4. PubMed ID: 8252522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of sudden blindness due to a pituitary adenoma coincidentally infected with methicillin-resistant Staphylococcus aureus (MRSA).
    Bakker NA; Hoving EW
    Acta Neurochir (Wien); 2010 Jun; 152(6):1079-80. PubMed ID: 19915791
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical practice. Prolactinomas.
    Klibanski A
    N Engl J Med; 2010 Apr; 362(13):1219-26. PubMed ID: 20357284
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
    Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
    Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report.
    Koguchi M; Nakahara Y; Ebashi R; Ogata A; Shimokawa S; Masuoka J; Abe T
    J Med Case Rep; 2019 Jan; 13(1):18. PubMed ID: 30660191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.